Lymphoma Clinical Trials

A listing of Lymphoma medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 276 clinical trials
An Efficacy and Safety Study of Luspatercept (ACE-536) Versus Placebo in Subjects With Myeloproliferative Neoplasm-Associated Myelofibrosis on Concomitant JAK2 Inhibitor Therapy and Who Require Red Blood Cell Transfusions

The purpose of this Phase 3 study is to evaluate the efficacy and safety of Luspatercept compared with placebo in subjects with myeloproliferative neoplasm (MPN)-associated Myelofibrosis (MF) and anemia on concomitant Janus kinase 2 (JAK2) inhibitor therapy and who require red blood cell count (RBC) transfusions. The study is divided …

bilateral oophorectomy
anemia
cancer
vasectomy
  • 28 views
  • 20 Jan, 2022
  • 145 locations
A Study to Investigate Blinatumomab in Combination With Chemotherapy in Patients With Newly Diagnosed B-Lymphoblastic Leukemia

lymphoma with or without Down syndrome. Monoclonal antibodies, such as blinatumomab, may induce changes in the body's immune system and may interfere with the ability of cancer cells to grow and spread

white blood cell count
pegaspargase
b-cell acute lymphoblastic leukemia
leucovorin
leukemia
  • 92 views
  • 19 Jan, 2022
  • 119 locations
A Study Of Two Inotuzumab Ozogamicin Doses in Relapsed/ Refractory Acute Lymphoblastic Leukemia Transplant Eligible Patients

This study will explore 2 different doses of inotuzumab ozogamicin including the dose that is approved and a lower dose. The main purpose of this study is to evaluate whether a dose of inotuzumab ozogamicin, lower than the approved dose, could be recommended for adult patient with relapsed or refractory …

lymphoblasts
lymphoblastic lymphoma
blast cells
refractory acute lymphoblastic leukemia
induction chemotherapy
  • 181 views
  • 19 Jan, 2022
  • 44 locations
Basket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK 1/2/3 (Trk A/B/C), ROS1, or ALK Gene Rearrangements (Fusions) (STARTRK-2)

This is an open-label, multicenter, global Phase 2 basket study of entrectinib (RXDX-101) for the treatment of patients with solid tumors that harbor an NTRK1/2/3, ROS1, or ALK gene fusion. Patients will be assigned to different baskets according to tumor type and gene fusion.

ROS1
solid tumour
small molecule
leptomeningeal carcinomatosis
lymphoma
  • 2 views
  • 26 Jan, 2022
  • 87 locations
Durvalumab and Tremelimumab for Pediatric Malignancies

The purpose of the study is to determine the recommended dose of durvalumab and tremelimumab (immunotherapy drugs) in pediatric patients with advanced solid and hematological cancers and expand in a second phase to test the efficacy of these drugs once this dose is determined

lymphoma
cancer
durvalumab
acute leukemia
leukemia
  • 15 views
  • 12 Jan, 2022
  • 26 locations
Genetic Testing in Screening Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The ALCHEMIST Screening Trial)

This ALCHEMIST trial studies genetic testing in screening patients with stage IB-IIIA non-small cell lung cancer that has been or will be removed by surgery. Studying the genes in a patient's tumor cells may help doctors select the best treatment for patients that have certain genetic changes.

squamous cell carcinoma
carboplatin
nivolumab
erlotinib
adenocarcinoma
  • 1114 views
  • 20 Jan, 2022
  • 1142 locations
Auto Stem Cell Transplant for Lymphoma Patients

This is a phase II study of autologous transplant for patients with Hodgkin (HL) and non-Hodgkin lymphomas (NHL) including those who are HIV positive.

refractory lymphoma
chemotherapy regimen
large b-cell lymphoma
leukemia
hodgkin's disease
  • 6 views
  • 19 Jan, 2022
  • 1 location
Idiotypic Vaccination for Follicular Lymphoma Patients (FLIDVAX2006)

Poor prognosis follicular lymphoma patients have an estimated median overall survival of 5-6 years. The proposed trial offers life-time idiotypic vaccination to all such patients in first

rituximab
  • 26 views
  • 23 Jan, 2022
  • 1 location
Study of TG-1801 in Subjects With B-Cell Lymphoma

Phase 1 first in human Study to Assess the Bispecific Antibody TG-1801 in Subjects with B-Cell Lymphoma

anti-cd20 monoclonal antibody
platelet count
refractory b-cell non-hodgkin lymphoma
neutrophil count
g-csf
  • 20 views
  • 19 Jan, 2022
  • 5 locations
Pembrolizumab in Untreated B-Cell Non-Hodgkin Lymphoproliferative Diseases

This phase II trial studies how well pembrolizumab works in treating patients with B-cell non-Hodgkin lymphoproliferative diseases that have not been treated. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and …

conjugated bilirubin
marginal zone lymphoma
monoclonal protein
follicular lymphoma
metastasis
  • 18 views
  • 17 Jan, 2022
  • 1 location